Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Jupiter Neurosciences, Inc. (JUNS) had Free Cash Flow per Share of $-0.04 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.02M |
|
$-2.06M |
|
$0.00M |
|
$0.01M |
|
$1.98M |
|
$-1.96M |
|
$-0.10M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-1.96M |
|
$-1.96M |
|
35.26M |
|
35.26M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$3.41M |
|
-- |
|
$0.54M |
|
$3.95M |
|
$6.73M |
|
-- |
|
-- |
|
$6.73M |
|
$-2.78M |
|
$-2.78M |
|
$-2.78M |
|
36.28M |
|
| Cash Flow Statement Financials | |
$-1.43M |
|
-- |
|
$0.01M |
|
$3.79M |
|
$2.36M |
|
$-1.43M |
|
$0.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.51 |
|
-- |
|
-- |
|
-- |
|
-1.73 |
|
76.61% |
|
-10524.34% |
|
-10524.34% |
|
-- |
|
-11054.89% |
|
-11054.89% |
|
$-1.43M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
-- |
|
-- |
|
74.08% |
|
74.08% |
|
-52.22% |
|
74.08% |
|
$-0.08 |
|
|
Free Cash Flow per Share |
$-0.04 |
$-0.04 |
|